NCT00099580 - PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions

Congestive Heart Failure

Interventions

DRUG

AC2592

continuous subcutaneous infusion (via pump), dose based on subject body weight

DRUG

placebo

continuous subcutaneous infusion (via pump), dose based on subject body weight

Trial Locations (29)

Unknown

Research Site, Beverly Hills

Research Site, Mission Viejo

Research Site, New Haven

Research Site, Washington D.C.

Research Site, Jacksonville

Research Site, Tampa

Research Site, Peoria

Research Site, Springfield

Research Site, Winfield

Research Site, Wichita

Research Site, Baton Rouge

Research Site, Shreveport

Research Site, Auburn

Research Site, Boston

Research Site, Detroit

Research Site, Lincoln

Research Site, Chapel Hill

Research Site, Durham

Research Site, Cincinnati

Research Site, Cleveland

Research Site, Columbus

Research Site, Oklahoma City

Research Site, Medford

Research Site, Portland

Research Site, Philadelphia

Research Site, Charleston

Research Site, Knoxville

Research Site, Dallas

Research Site, Houston